REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics

Carhart-Harris, R.L., Friston, K.J.·2019·Pharmacological Reviews
DOI 10.1124/pr.118.017160

Cited by (999)

Items 101–200 of 999

  1. The Emerging Field of Psychedelic Psychotherapy
    Gregory Barber, Scott T. Aaronson · 2022 · Current Psychiatry Reports
  2. Investigation of advanced mindfulness meditation “cessation” experiences using EEG spectral analysis in an intensively sampled case study
    Avijit Chowdhury, Remko van Lutterveld, Ruben Laukkonen, Heleen A. Slagter, Daniel M. Ingram, Matthew D. Sacchet · 2023 · Neuropsychologia
  3. A Psychoanalytic Perspective on Psychedelic Experience
    Jeffrey R. Guss · 2022 · Psychoanalytic Dialogues
  4. Pattern breaking: a complex systems approach to psychedelic medicine
    Inês Hipólito, Jonas Mago, Fernando E. Rosas, Robin Lester Carhart-Harris · 2023 · Neuroscience of Consciousness
  5. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention
    Rotem Petranker, Thomas Anderson, Larissa Jasmine Maier, Monica Jane Barratt, Jason Ferris, ADAM R. WINSTOCK · 2020 · Journal of Psychopharmacology
  6. Brain Entropy During Aging Through a Free Energy Principle Approach
    Filippo Cieri, Xiaowei Zhuang, Jessica Caldwell, Dietmar Cordes · 2021 · Frontiers in Human Neuroscience
  7. Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
    James E. Glazer, Conor H. Murray, Robin Nusslock, Royce Lee, Harriet de Wit · 2022 · Neuropsychopharmacology
  8. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics
    Marco Aqil, Leor Roseman · 2022 · Neuropharmacology
  9. A whole-brain model of the neural entropy increase elicited by psychedelic drugs
    Ruben A Herzog, Pedro A. M. Mediano, Fernando E. Rosas, Paul Lodder, Robin Lester Carhart-Harris, Yonatan Sanz Perl, Enzo Tagliazucchi, Rodrigo Cofré · 2023 · Scientific Reports
  10. Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
    Alaina M. Jaster, Javier González‐Maeso · 2023 · Molecular Psychiatry
  11. Beyond the veil of duality—topographic reorganization model of meditation
    Austin Clinton Cooper, Bianca Ventura, Georg Northoff · 2022 · Neuroscience of Consciousness
  12. Psychedelics and psychological flexibility – Results of a prospective web-survey using the Acceptance and Action Questionnaire II
    Close, James B., Hajien, Eline C., Watts, Rosalind, Roseman, Leor, Carhart-Harris, Robin L. · 2020 · Journal of Contextual Behavioral Science
  13. On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)
    Adam Safron, Arthur Juliani, Nicco Reggente, Victoria Klimaj, Matthew W. Johnson · 2025 · Neuroscience of Consciousness
  14. Understanding brain states across spacetime informed by whole-brain modelling
    Jakub Vohryzek, Joana Cabral, Peter Vuust, Gustavo Deco, Morten L. Kringelbach · 2022 · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences
  15. Effective Connectivity of Functionally Anticorrelated Networks Under Lysergic Acid Diethylamide
    Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, Gary F. Egan, Katrin H. Preller, Adeel Razi · 2022 · Biological Psychiatry
  16. Differential effects of propofol and ketamine on critical brain dynamics
    Thomas F. Varley, Olaf Sporns, Aina Puce, John M. Beggs · 2020 · PLoS Computational Biology
  17. First few seconds for flow: a comprehensive proposal of the neurobiology and neurodynamics of state onset
    Kotler, Steven, Mannino, Michael, Kelso, Scott, Huskey, Richard · 2022 · Neuroscience & Biobehavioral Reviews
  18. Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca
    Agin-Liebes, Gabrielle, Zeifman, Richard, Luoma, Jason B, Garland, Eric L, Campbell, W Keith, Weiss, Brandon · 2022 · Journal of Psychopharmacology
  19. Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis
    Agin-Liebes, Gabrielle, Ekman, Eve, Anderson, Brian, Malloy, Maxx, Haas, Alexandra, Woolley, Josh · 2024 · Journal of Humanistic Psychology
  20. Psychedelic drugs and perception: a narrative review of the first era of research
    Jacob S. Aday, Julia R. Wood, Emily K. Bloesch, Christopher C. Davoli · 2021 · Reviews in the Neurosciences
  21. Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
    Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael Zingman, Katherine Kim, Alexandra Haas, Lindsey T. Owens, Ursula A. Rogers, Michael P. Bogenschutz · 2023 · Psychology of Addictive Behaviors
  22. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain
    Manoj K. Doss, Darrick G. May, Matthew W. Johnson, John M Clifton, Sidnee L. Hedrick, Thomas Edward Prisinzano, Roland R. Griffiths, Frederick Streeter Barrett · 2020 · Scientific Reports
  23. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
    Skosnik, Patrick D, Sloshower, Jordan, Safi-Aghdam, Hamideh, Pathania, Surbhi, Syed, Shariful, Pittman, Brian, D’Souza, Deepak C · 2023 · Journal of Psychopharmacology
  24. Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
    Carhart-Harris, Robin L, Wagner, Anne C, Agrawal, Manish, Kettner, Hannes, Rosenbaum, Jerold F, Gazzaley, Adam, Nutt, David J, Erritzoe, David · 2022 · Journal of Psychopharmacology
  25. Rethinking therapeutic strategies for anorexia nervosa: insights from psychedelic medicine and animal models
    Foldi, Claire J., Liknaitzky, Paul, Williams, Martin, Oldfield, Brian J. · 2020 · Frontiers in Neuroscience
  26. A neurobiological perspective on social influence: Serotonin and social adaptation
    Patricia Duerler, Franz X. Vollenweider, Katrin H. Preller · 2022 · Journal of Neurochemistry
  27. Exploring DMT: Endogenous role and therapeutic potential
    Jakub Schimmelpfennig, Kamila Jankowiak-Siuda · 2025 · Neuropharmacology
  28. Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics
    David R. Glowacki, Rhoslyn Roebuck Williams, Mark Wonnacott, Olivia Maynard, Rachel Freire, James E. Pike, Mike Chatziapostolou · 2022 · Scientific Reports
  29. Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
    Igor Magaraggia, Zilla Kuiperes, Rudy Schreiber · 2021 · Neurobiology of Learning and Memory
  30. RETRACTED ARTICLE: A mechanistic model of the neural entropy increase elicited by psychedelic drugs
    Ruben A Herzog, Pedro A. M. Mediano, Fernando E. Rosas, Robin Lester Carhart-Harris, Yonatan Sanz Perl, Enzo Tagliazucchi, Rodrigo Cofré · 2020 · Scientific Reports · Retracted
  31. Review of otential sychedelic reatments for PTSD
    Ryan L. Henner, Matcheri S. Keshavan, Kevin P. Hill · 2022 · Journal of the Neurological Sciences
  32. Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
    Simon Ruffell, Max Crosland‐Wood, Rob Palmer, Nige Netzband, WaiFung Tsang, Brandon Weiss, Sam Gandy, Tessa Cowley‐Court, Andreas Halman, Diana McHerron et al. · 2023 · Psychiatry and Clinical Neurosciences Reports
  33. Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences
    Eirini K. Argyri, Jules Evans, David P. Luke, Pascal Michael, Katrina Michelle, Cyrus Rohani-Shukla, Shayam Suseelan, Ed Prideaux, Rosalind G. McAlpine, Ashleigh Murphy-Beiner et al. · 2025 · PLoS ONE
  34. Psilocybin Therapeutic Research: The Present and Future Paradigm
    Robert B. Kargbo · 2020 · ACS Medicinal Chemistry Letters
  35. Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC
    Murray, Conor H., Huang, Zhengyi, Lee, Royce, de Wit, Harriet · 2022 · Neuropsychopharmacology
  36. Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
    Abigail E. Calder, Seline Mock, Nicole Friedli, Patrick Rodolphe Pasi, Gregor Hasler · 2023 · European Neuropsychopharmacology
  37. Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
    Jonathan W. Kanen, Qiang Luo, Mojtaba Rostami Kandroodi, Rudolf N. Cardinal, Trevor William Robbins, David John Nutt, Robin Lester Carhart-Harris, Hanneke E.M. den Ouden · 2022 · Psychological Medicine
  38. Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects
    Rantamäki, Tomi, Kohtala, Samuel · 2020 · Pharmacological Reviews
  39. The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis
    Bruno Roméo, Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, Ammar Amirouche, Aurore Bezo, Pascale Piolino, Amine Benyamina · 2025 · Neuroscience & Biobehavioral Reviews
  40. Topological analysis of differential effects of ketamine and propofol anaesthesia on brain dynamics
    Thomas F. Varley, Vanessa C. Denny, Olaf Sporns, Alice Patania · 2021 · Royal Society Open Science
  41. Prefrontal contributions to the stability and variability of thought and conscious experience
    Andre Zamani, Robin Lester Carhart-Harris, Kalina Christoff A · 2021 · Neuropsychopharmacology
  42. Psychedelic-assisted psychotherapy: Where is the psychotherapy research
    Aday, Jacob S., Horton, David, Fernandes-Osterhold, Gisele, O’Donovan, Aoife, Bradley, Ellen R., Rosen, Raymond C., Woolley, Joshua D. · 2024 · Psychopharmacology
  43. Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
    Emma I Kopra, Jason Ferris, James Rucker, Benjamin McClure, Allan Hunter Young, Caroline S. Copeland, ADAM R. WINSTOCK · 2022 · Journal of Psychopharmacology
  44. Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences
    Juuso Kähönen · 2023 · Frontiers in Psychology
  45. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin
    Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, Gary F. Egan, Katrin H. Preller, Adeel Razi · 2024 · Biological Psychiatry
  46. Seeing without self: Discovering new meaning with psychedelic-assisted psychotherapy
    Lawrence G. Fischman · 2019 · Neuropsychoanalysis
  47. Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States
    Mihai Avram, Helena Victoria Rogg, Alexandra I. Korda, Christina Andreou, Felix Müller, Stefan Borgwardt · 2021 · Frontiers in Psychiatry
  48. Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents
    Caroline T. Golden, Paul T. Chadderton · 2022 · Scientific Reports
  49. The costs and benefits of psychedelics on cognition and mood
    Ceyda Sayalı, Frederick Streeter Barrett · 2023 · Neuron
  50. Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research
    Julia Bornemann, James B. Close, Meg J. Spriggs, Robin Lester Carhart-Harris, Leor Roseman · 2021 · Frontiers in Psychiatry
  51. Mindfulness meditation and psychedelics: potential synergies and commonalities
    Holas, Paweł, Kamińska, Justyna · 2023 · Pharmacological Reports
  52. The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
    Onofrj, Marco, Russo, Mirella, Delli Pizzi, Stefano, De Gregorio, Danilo, Inserra, Antonio, Gobbi, Gabriella, Sensi, Stefano L. · 2023 · Translational Psychiatry
  53. Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD
    Timothy Lawn, Ottavia Dipasquale, Alexandros Vamvakas, Ioannis Tsougos, Mitul Ashok Mehta, Matthew A. Howard · 2022 · Psychopharmacology
  54. What it is like to be a bit: an integrated information decomposition account of emergent mental phenomena
    Andrea I. Luppi, Pedro A. M. Mediano, Fernando E. Rosas, David J Harrison, Robin Lester Carhart-Harris, Daniel Bor, Emmanuel Andreas Stamatakis · 2021 · Neuroscience of Consciousness
  55. Neuroimaging in psychedelic drug development: past, present, and future
    Matthew B. Wall, Rebecca Harding, Rayyan R. Zafar, Eugenii A. Rabiner, David Nutt, David Erritzøe · 2023 · Molecular Psychiatry
  56. Effects of DMT on mental health outcomes in healthy volunteers
    Christopher Timmermann, Richard J. Zeifman, David Erritzøe, David Nutt, Robin Lester Carhart-Harris · 2024 · Scientific Reports
  57. Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression
    Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Lester Carhart-Harris, Morten L. Kringelbach · 2024 · Nature Mental Health
  58. Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy
    Eleftheriou, Maria Eleni, Thomas, Emily · 2021 · Frontiers in Psychiatry
  59. Altered states phenomena induced by visual flicker light stimulation
    Marie Therese Bartossek, Johanna Kemmerer, Timo Torsten Schmidt · 2021 · PLoS ONE
  60. Therapeutic Alliance as Active Inference: The Role of Therapeutic Touch and Biobehavioural Synchrony in Musculoskeletal Care
    Zoe McParlin, Francesco Cerritelli, Giacomo Rossettini, Karl John Friston, Jorge Eduardo Esteves · 2022 · Frontiers in Behavioral Neuroscience
  61. Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives
    Yvan Beaussant, Justin J. Sanders, Zachary S. Sager, James A. Tulsky, Ilana Monica Braun, Craig D. Blinderman, Anthony P. Bossis, Ira Robert Byock · 2020 · Journal of Palliative Medicine
  62. Relational Processes in Ayahuasca Groups of Palestinians and Israelis
    Leor Roseman, Yiftach Ron, Antwan Saca, Natalie Lyla Ginsberg, Lisa Xiaolu Luan, Nadeem Karkabi, Rick Doblin, Robin Lester Carhart-Harris · 2021 · Frontiers in Pharmacology
  63. Consciousness in active inference: Deep self-models, other minds, and the challenge of psychedelic-induced ego-dissolution
    Deane, George · 2021 · Neuroscience of Consciousness
  64. Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy
    Michael Koslowski, Matthew W. Johnson, Gerhard Gründer, Felix Betzler · 2021 · Current Addiction Reports
  65. Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans
    Flora Moujaes, Katrin H. Preller, Jie Lisa Ji, John D. Murray, Lucie Berkovitch, Franz X. Vollenweider, Alan Anticevic · 2022 · Biological Psychiatry
  66. With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
    Daniel Villiger, Manuel Trachsel · 2023 · Journal of Medical Ethics
  67. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
    Peter Bedford, Daniel J. Hauke, Zheng Wang, Volker Röth, Monika Nagy-Huber, Friederike Holze, Laura Ley, Patrick Vizeli, Matthias E. Liechti, Stefan Borgwardt et al. · 2023 · Neuropsychopharmacology
  68. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap
    Henry Szechtman, Brian Herbert Harvey, Erik Z. Woody, Kurt Leroy Hoffman · 2019 · Pharmacological Reviews
  69. The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
    Lisa Page, Ahmad Rehman, Habib Syed, Kathryn Forcer, Graham Campbell · 2021 · Frontiers in Psychiatry
  70. Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy
    Sascha B. Thal, Stephen Jason Bright, Jason M. Sharbanee, Tobias Wenge, Petra Skeffington · 2021 · Frontiers in Psychology
  71. From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
    Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner, Taylor Lyons, Fernando E. Rosas, Pedro A. M. Mediano, David Erritzøe, Robin Lester Carhart-Harris · 2025 · Scientific Reports
  72. Do psychedelics change beliefs?
    Hugh T. McGovern, Pantelis Leptourgos, Brendan T. Hutchinson, Philip Robert Corlett · 2022 · Psychopharmacology
  73. Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment
    C. J. Healy, Kellie Ann Lee, Wendy M. D'Andrea · 2021 · Chronic Stress
  74. Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism
    Katherine Cheung, Brian David Earp, Kyle Patch, David B. Yaden · 2025 · The American Journal of Bioethics
  75. 5-HT2AR and NMDAR psychedelics induce similar hyper-synchronous states in the rat cognitive-limbic cortex-basal ganglia system
    Ivani Brys, Sebastián A. Barrientos, Jon Ezra Ward, Jonathan Wallander, Per Petersson, Pär Halje · 2023 · Communications Biology
  76. The nature of consciousness in anaesthesia
    Javier Montupil, Paolo Cardone, Cécile Staquet, Arthur Bonhomme, Aline Defresne, Charlotte Martial, Naji Alnagger, Olivia Gosseries, Vincent Luce Bonhomme · 2023 · BJA Open
  77. The entropic tongue: Disorganization of natural language under LSD
    Camila Sanz, Carla Pallavicini, Facundo Carrillo, Federico Zamberlán, Mariano Sigman, Natália Bezerra Mota, Mauro Copelli, Sidarta Tollendal Gomes Ribeiro, David Nutt, Robin Lester Carhart-Harris et al. · 2020 · Consciousness and Cognition
  78. Integrating Cybernetic Big Five Theory with the free energy principle: A new strategy for modeling personalities as complex systems
    Adam Safron, Colin G. DeYoung · 2021 · Elsevier eBooks
  79. The Treatment of Substance Use Disorders: Recent Developments and New Perspectives
    Annika Rosenthal, Claudia Ebrahimi, Friederike Wedemeyer, Nina Romanczuk‐Seiferth, Anne Beck · 2022 · Neuropsychobiology
  80. Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis
    John Richard Kelly, Gerard A. Clarke, Andrew Harkin, Sinéad C. Corr, Stephen D. Galvin, Vishnu Pradeep, John F. Cryan, Veronica O’Keane, Timothy G. Dinan · 2022 · International Journal of Clinical and Health Psychology
  81. The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
    Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, Nathalie Goyette, Alexandre Lehmann, Karl Julian Looper, David Erritzøe, Shannon Dames, Gustavo Turecki, Soham Rej et al. · 2023 · Frontiers in Psychiatry
  82. Psychedelics for treatment resistant depression: are they game changers?
    Michail Kalfas, Rosie H. Taylor, Dimosthenis Tsapekos, Allan Hunter Young · 2023 · Expert Opinion on Pharmacotherapy
  83. Increased sensitivity to strong perturbations in a whole-brain model of LSD
    Beatrice Jobst, Selen Atasoy, Adrián Ponce‐Alvarez, Ana Sanjuán, Leor Roseman, Mendel Kaelen, Robin Lester Carhart-Harris, Morten L. Kringelbach, Gustavo Deco · 2021 · NeuroImage
  84. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis
    Haley Maria Dourron, Camilla K. Strauss, Peter S. Hendricks · 2022 · Pharmacological Reviews
  85. Psilocybin and Other Classic Psychedelics in Depression
    David Nutt, Joseph M. Peill, Brandon Weiss, Kate Godfrey, Robin Lester Carhart-Harris, David Erritzøe · 2023 · Current topics in behavioral neurosciences
  86. Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
    Conor H. Murray, Joel Frohlich, Connor J. Haggarty, Ilaria Tare, Royce Lee, Harriet de Wit · 2024 · Neuropsychopharmacology
  87. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
    Klemens Egger, Helena Aicher, Paul D. Cumming, Milan Scheidegger · 2024 · Cellular and Molecular Life Sciences
  88. Volitional mental absorption in meditation: Toward a scientific understanding of advanced concentrative absorption meditation and the case of jhana
    Winson Fu Zun Yang, Terje Sparby, Malcolm Wright, Eunmi Kim, Matthew D. Sacchet · 2024 · Heliyon
  89. Network Analysis of Time Series: Novel Approaches to Network Neuroscience
    Thomas F. Varley, Olaf Sporns · 2022 · Frontiers in Neuroscience
  90. Psychedelics in the treatment of unipolar and bipolar depression
    Oliver Gero Bosch, Simon Halm, Erich Seifritz · 2022 · International Journal of Bipolar Disorders
  91. Associations between classic psychedelics and nicotine dependence in a nationally representative sample
    Grant M Jones, Joshua Lipson, M. Nock · 2022 · Scientific Reports
  92. Exploring mechanisms of psychedelic action using neuroimaging
    David Erritzøe, Christopher Timmermann, Kate E.M. Godfrey, Pedro Castro-Rodrigues, Joseph M. Peill, Robin Lester Carhart-Harris, David Nutt, Matthew B. Wall · 2024 · Nature Mental Health
  93. Neurophenomenological Investigation of Mindfulness Meditation “Cessation” Experiences Using EEG Network Analysis in an Intensively Sampled Adept Meditator
    Remko van Lutterveld, Avijit Chowdhury, Daniel M. Ingram, Matthew D. Sacchet · 2024 · Brain Topography
  94. Somatostatin interneurons activated by 5-HT2A receptor suppress slow oscillations in medial entorhinal cortex
    Roberto De Filippo, Benjamin R. Rost, Alexander Stumpf, Claire Cooper, John J. Tukker, Christoph Harms, Prateep Sanker Beed, Dietmar Schmitz · 2021 · eLife
  95. Implicit–explicit gradient of nondual awareness or consciousness as such
    Zoran Josipovic · 2021 · Neuroscience of Consciousness
  96. Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca
    Weiss, Brandon, Wingert, Aleksandra, Erritzoe, David, Campbell, W. Keith · 2023 · Scientific Reports
  97. Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine
    Dornbierer, Dario A., Marten, Laurenz, Mueller, Jovin, Aicher, Helena D., Mueller, Michael J., Boxler, Martina, Kometer, Michael, Kosanic, Davor, von Rotz, Robin, Puchkov, Maxim et al. · 2023 · Frontiers in Pharmacology
  98. The Acute Effects of Psychoactive Drugs on Emotional Episodic Memory Encoding, Consolidation, and Retrieval
    Manoj K. Doss, H. de Wit, D. Gallo · 2023 · Neuroscience and Biobehavioral Reviews
  99. Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder
    Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Lester Carhart-Harris, David Erritzøe · 2024 · International Journal of Mental Health and Addiction
  100. LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics
    Giulio Ruffini, Giada Damiani, Diego Lozano‐Soldevilla, Nikolas Deco, Fernando E. Rosas, Narsis A. Kiani, Adrián Ponce‐Alvarez, Morten L. Kringelbach, Robin Lester Carhart-Harris, Gustavo Deco · 2023 · PLoS Computational Biology